Intertumoral Heterogeneity within Medulloblastoma Subgroups

Cavalli, Florence M.G., Remke, Marc, Rampasek, Ladislav, Peacock, John, Shih, David J.H., Luu, Betty, Garzia, Livia, Torchia, Jonathon +87 more·2017·Cancer Cell
DOI 10.1016/j.ccell.2017.05.005

Cited by (1,000)

Items 501–600 of 1,000

  1. Human Sialic acid O-acetyl esterase (SIAE) – mediated changes in sensitivity to etoposide in a medulloblastoma cell line
    Rebecca L. Mather, Katie F. Loveson, Helen L. Fillmore · 2019 · Scientific Reports
  2. Restoration of miR-193a expression is tumor-suppressive in MYC amplified Group 3 medulloblastoma
    Harish Shrikrishna Bharambe, Annada Anil Joshi, Kedar Yogi, Sadaf Kazi, Neelam Vishwanath Shirsat · 2020 · Acta Neuropathologica Communications
  3. Ubiquitin ligases and medulloblastoma: genetic markers of the four consensus subgroups identified through transcriptome datasets
    Jerry P. Vriend, Mojgan Rastegar · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  4. A transcriptome-based classifier to determine molecular subtypes in medulloblastoma
    Komal S. Rathi, Sherjeel Arif, Mateusz Koptyra, Ammar S. Naqvi, Deanne M. Taylor, Phillip B. Storm, Adam Cain Resnick, Jo Lynne Rokita, Pichai Raman · 2020 · PLoS Computational Biology
  5. Surgical management of posterior fossa medulloblastoma in children: The Lyon experience
    Blandine Grassiot, Pierre-Aurélien Beuriat, Federico Di Rocco, Pierre Leblond, Cécile Faure‐Conter, Alexandru Szathmári, C. Mottolèse · 2021 · Neurochirurgie
  6. Integrated molecular analysis of adult sonic hedgehog (SHH)-activated medulloblastomas reveals two clinically relevant tumor subsets with VEGFA as potent prognostic indicator
    Andrey Korshunov, Konstantin Okonechnikov, Damian Stichel, Marina Vladimirovna Ryzhova, Daniel Schrimpf, Felix Sahm, Philipp Sievers, O V Absalyamova, Olga Zheludkova, Андрей Владимирович Голанов et al. · 2021 · Neuro-Oncology
  7. Gene expression signatures predict response to therapy with growth hormone
    Adam Stevens, Philip George Murray, Chiara De Leonibus, Terence Garner, Ekaterina B Koledova, Geoffrey R. Ambler, Jia-Woei Hou, Klaus Kapelari, Jean‐Pierre Salles, Gerhard Binder et al. · 2021 · The Pharmacogenomics Journal
  8. Functional Genomics of PRUNE1 in Neurodevelopmental Disorders (NDDs) Tied to Medulloblastoma (MB) and Other Tumors
    Francesca Bibbò, Carmen Sorice, Veronica Ferrucci, Massimo Zollo · 2021 · Frontiers in Oncology
  9. Bromodomain and Extra-Terminal Protein Inhibitors: Biologic Insights and Therapeutic Potential in Pediatric Brain Tumors
    Andrew P. Groves, Jessica R. Clymer, Mariella G. Filbin · 2022 · Pharmaceuticals
  10. Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma
    Allison K. Pribnow, Barbara Jonchère, Jingjing Liu, Kyle S. Smith, Olivia Campagne, Ke Xu, Sarah Robinson, Yogesh T. Patel, Arzu Onar‐Thomas, Gang Wu et al. · 2022 · Molecular Cancer Therapeutics
  11. Cancer risk and tumour spectrum in 172 patients with a germline SUFU pathogenic variation: a collaborative study of the SIOPE Host Genome Working Group
    Léa Guerrini‐Rousseau, Julien Masliah‐Planchon, Sebastian M. Waszak, Pia Alhopuro, Patrick R. Benusiglio, Franck Bourdeaut, Ines B. Brecht, Giada Del Baldo, Sandeep Kumar Dhanda, Maria Luisa Garrè et al. · 2022 · Journal of Medical Genetics
  12. Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression
    Andrey Korshunov, Konstantin Okonechnikov, Damian Stichel, Daniel Schrimpf, Alberto Delaidelli, Svenja Tonn, Martin Mynarek, Philipp Sievers, Felix Sahm, David Jones et al. · 2022 · Acta Neuropathologica
  13. MRI Radiomics Signature of Pediatric Medulloblastoma Improves Risk Stratification Beyond Clinical and Conventional MR Imaging Features
    Hui Wen Zheng, Jinning Li, Huanhuan Liu, Ting Gui, Qiufeng Yin, Rui Li, Ming Liu, Yuzhen Zhang, Shaofeng Duan, Yuhua Li et al. · 2022 · Journal of Magnetic Resonance Imaging
  14. ABL1 and ABL2 promote medulloblastoma leptomeningeal dissemination
    Jill K. Jones, Hengshan Zhang, Anne-Marie Lyne, Florence M.G. Cavalli, Wafa E. Hassen, Kevin Stevenson, Reb Kornahrens, Yuanfan Yang, Sean Li, Samuel Dell et al. · 2023 · Neuro-Oncology Advances
  15. From One to Many: Further Refinement of Medulloblastoma Subtypes Offers Promise for Personalized Therapy
    Abhishek Amar Bavle, Donald Williams Parsons · 2017 · Cancer Cell
  16. Effective and safe tumor inhibition using vinblastine in medulloblastoma
    Liana Figueiredo Nobre, David Pauck, Brian J. Golbourn, Mara Maue, Éric Bouffet, Marc Remke, Vijay Ramaswamy · 2019 · Pediatric Blood & Cancer
  17. Semaphorin Regulation by the Chromatin Remodeler CHD7: An Emerging Genetic Interaction Shaping Neural Cells and Neural Crest in Development and Cancer
    Antonella Lettieri, Roberto Oleari, Alyssa Julia Jennifer Paganoni, Cristina Gervasini, Valentina Massa, Alessandro Fantin, Anna Maria Cariboni · 2021 · Frontiers in Cell and Developmental Biology
  18. Downregulation of ARID1B, a tumor suppressor in the WNT subgroup medulloblastoma, activates multiple oncogenic signaling pathways
    Akash Deogharkar, Satishkumar Vishram Singh, Harish Shrikrishna Bharambe, Raikamal Paul, Aliasgar V. Moiyadi, Atul H Goel, Prakash M. Shetty, Sridhar Epari, Tejpal Gupta, Rakesh Jalali et al. · 2021 · Human Molecular Genetics
  19. CREB signaling activity correlates with differentiation and survival in medulloblastoma
    Inna Armandari, Walderik W. Zomerman, Sabine L. A. Plasschaert, Marlinde J. Smit, Tosca E. I. Martini, Eduardo Sabino de Camargo Magalhães, Shanna M. Hogeling, Geesina C. Rozema-Huizinga, Harm Jan Lourens, Tiny Meeuwsen-de Boer et al. · 2021 · Scientific Reports
  20. Enrichment of Tumor-Infiltrating B Cells in Group 4 Medulloblastoma in Children
    Kuo-Sheng Wu, Ting-Yan Jian, Shian‐Ying Sung, Chia‐Ling Hsieh, Man‐Hsu Huang, Chia‐Lang Fang, Tai‐Tong Wong, Yu‐Ling Lin · 2022 · International Journal of Molecular Sciences
  21. The Multiple Roles of Peptidyl Prolyl Isomerases in Brain Cancer
    Stefano Stifani · 2018 · Biomolecules
  22. Single-cell multi-omics identifies metabolism-linked epigenetic reprogramming as a driver of therapy-resistant medulloblastoma
    Bethany L. Veo, Dong Wang, John A. DeSisto, Angela M. Pierce, Breauna Brunt, Pradeep Bompada, Andrew M. Donson, Andrew E. Goodspeed, Kiara Smart, Nicholas K. Foreman et al. · 2025 · Nature Communications
  23. Immune microenvironment of medulloblastoma: The association between its molecular subgroups and potential targeted immunotherapeutic receptors
    Maher E. Kurdi, Nasser Mulla, Husam M. Malibary, Ahmed Khamis Bamaga, Motaz M. Fadul, Eyad Faizo, Sahar Hakamy, Saleh Salem Baeesa · 2023 · World Journal of Clinical Oncology
  24. MYC overexpression and SMARCA4 loss cooperate to drive medulloblastoma formation in mice
    Carolin Göbel, Shweta Godbole, Melanie Schoof, Dörthe Holdhof, Catena Kresbach, Carolin Loose, Julia E. Neumann, Ulrich Schüller · 2023 · Acta Neuropathologica Communications
  25. The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma
    Nan Qin, Eunice Paisana, Daniel J. Picard, Gabriel Leprivier, Maike Langini, Carlos Custódia, Rita Cascão, Catleen Conrad, Mirko Peitzsch, Anja Stefanski et al. · 2023 · Journal of Neuro-Oncology
  26. A syngeneic spontaneous zebrafish model of tp53-deficient, EGFRvIII, and PI3KCAH1047R-driven glioblastoma reveals inhibitory roles for inflammation during tumor initiation and relapse in vivo
    Alex Weiss, Cassandra D’Amata, Bret J. Pearson, Madeline N. Hayes · 2024 · eLife
  27. Multiparametric MRI-based machine learning system of molecular subgroups and prognosis in medulloblastoma
    Ziyang Liu, Sikang Ren, Heng Zhang, Zhiyi Liao, Zhiming Liu, Xu An, Jian Cheng, Chunde Li, Jian Feng Gong, Haijun Niu et al. · 2025 · European Radiology
  28. Long Noncoding RNAs: Emerging Players in Medulloblastoma
    Pietro Laneve, Jessica N. Rea, Elisa Caffarelli · 2019 · Frontiers in Pediatrics
  29. Deficiency in the Treatment Description of mTOR Inhibitor Resistance in Medulloblastoma, a Systematic Review
    Hajar Alammar, Rayan Nassani, Mana M. Alshehri, Alaa A. Aljohani, Bahauddeen M. Alrfaei · 2021 · International Journal of Molecular Sciences
  30. Elevated Kir2.1/nuclear N2ICD defines a highly malignant subtype of non-WNT/SHH medulloblastomas
    Yanxia Wang, Haibo Wu, Yong Ren, Shengqing Lv, Chengdong Ji, Dongfang Xiang, Mengsi Zhang, Huimin Lu, Wenjuan Fu, Qing Liu et al. · 2022 · Signal Transduction and Targeted Therapy
  31. OLIG2 Is a Determinant for the Relapse of MYC -Amplified Medulloblastoma
    Zhenhua Xu, Najiba Murad, Daniel Shiloh Malawsky, Ran Tao, Samuel Rivero-Hinojosa, Dörthe Holdhof, Ulrich Schüller, Peng Zhang, Christopher A. Lazarski, Brian R. Rood et al. · 2022 · Clinical Cancer Research
  32. The long non-coding RNA SPRIGHTLY and its binding partner PTBP1 regulate exon 5 skipping of SMYD3 transcripts in group 4 medulloblastomas
    Bongyong Lee, Keisuke Katsushima, Rudramani Pokhrel, Menglang Yuan, Stacie L. Stapleton, George I. Jallo, Robert J. Wechsler‐Reya, Charles G. Eberhart, Animesh Ray, Ranjan Joseph Perera · 2022 · Neuro-Oncology Advances
  33. Novel MRI deformation-heterogeneity radiomic features are associated with molecular subgroups and overall survival in pediatric medulloblastoma: Preliminary findings from a multi-institutional study
    Sukanya Raj Iyer, Marwa Ismail, Benita Tamrazi, Ralph Salloum, Peter M K de Blank, Ashley Margol, Ramón Correa, Jonathan Chen, Kaustav Bera, Volodymyr Statsevych et al. · 2022 · Frontiers in Oncology
  34. Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells
    Gintvile Valinciute, Jonas Ecker, Florian Selt, Thomas Hielscher, Romain Sigaud, Johannes Ridinger, Venu Thatikonda, Charlotte Gatzweiler, Sarah Robinson, Julie Talbot et al. · 2023 · Journal of Neuro-Oncology
  35. Group-specific cellular metabolism in Medulloblastoma
    Viktoria L. E. Funke, Carolin Walter, Viktoria Melcher, Lanying Wei, Sarah Sandmann, Marc Hotfilder, Julian Varghese, Natalie Jäger, Marcel Kool, David Jones et al. · 2023 · Journal of Translational Medicine
  36. EYA2 tyrosine phosphatase inhibition reduces MYC and prevents medulloblastoma progression
    Arthur R. Wolin, Melanie Y. Vincent, Taylor J. Hotz, Stephen Connor Purdy, Sheera R. Rosenbaum, Connor J. Hughes, Jessica Y. Hsu, Michael U. J. Oliphant, Brock A. Armstrong, Veronica M. Wessells et al. · 2023 · Neuro-Oncology
  37. Combination drug screen identifies synergistic drug interaction of BCL-XL and class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cells
    Simon Zeuner, Johanna Vollmer, Romain Sigaud, Sina Oppermann, Heike Peterziel, Dina ElHarouni, Ina Oehme, Olaf Witt, Till Milde, Jonas Ecker · 2024 · Journal of Neuro-Oncology
  38. Molecular-Clinical Correlation in Pediatric Medulloblastoma: A Cohort Series Study of 52 Cases in Taiwan
    Kuo-Sheng Wu, Donald Ming‐Tak Ho, Shiann‐Tarng Jou, Alice Lin-Tsing Yu, Huy Minh Tran, Muh‐Lii Liang, Hsin‐Hung Chen, Yi‐Yen Lee, Yi‐Wei Chen, Shih‐Chieh Lin et al. · 2020 · Cancers
  39. The Current Landscape of Targeted Clinical Trials in Non-WNT/Non-SHH Medulloblastoma
    David R. Ghasemi, Gudrun Fleischhack, Till Milde, Kristian W. Pajtler · 2022 · Cancers
  40. Pediatric Cancer
    Sujith Baliga, Torunn Ingrid Yock · 2019 · Hematology/Oncology Clinics of North America
  41. Circular and Fusion RNAs in Medulloblastoma Development
    Ani Azatyan, Peter G. Zaphiropoulos · 2022 · Cancers
  42. Childhood Cerebellar Tumors Mirror Conserved Fetal Transcriptional Programs
    Maria Claudia Vladoiu, Ibrahim El-Hamamy, Laura Donovan, Hamza Farooq, Borja Holgado, Vijay Ramaswamy, Stephen C. Mack, John JY Lee, Sachin A. Kumar, David Przelicki et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  43. Advancing Medulloblastoma Therapy in Pediatrics: Integrative Molecular Classification and Emerging Treatments
    David T. Kim, Michaela Uloho-Okundaye, Stephen C. Frederico, Santosh Guru, Min Jung Kim, Steven Daniel Chang · 2025 · Brain Sciences
  44. Fluid shear stress activates a targetable mechano-metastatic cascade to promote medulloblastoma metastasis
    Hyun-Kee Min, Hongyu Zhao, Alexander T. Bahcheli, Peng Pan, Jade Chan, Junsheng Chen, Esther Low, Yuxiao Zhou, Xian Wang, Savo Bajic et al. · 2025 · Nature Biomedical Engineering
  45. FigureYa: A Standardized Visualization Framework for Enhancing Biomedical Data Interpretation and Research Efficiency
    Xiaofan Lu, Kailai Li, Zongcheng Li, Anqi Lin, Long Zhao, Rongfang Shen, Zhou-Geng Xu, Jianing Gao, Dekang Lv, Yasi Zhang et al. · 2025 · iMetaMed
  46. Predisposition of Wingless Subgroup Medulloblastoma for Primary Tumor Hemorrhage
    Dominik Reisinger, Johannes Gojo, Gregor J. Kasprian, Christine Haberler, Andreas Peyrl, Amedeo A. Azizi, Lisa Mayr, Monika Chocholous, Marcel Kool, Thomas Czech et al. · 2019 · Neurosurgery
  47. Overview and recent advances in the targeting of medulloblastoma cancer stem cells
    Megan Rose Paul, Peter E. Zage · 2021 · Expert Review of Anticancer Therapy
  48. Decoding the Roles of Astrocytes and Hedgehog Signaling in Medulloblastoma
    Terence Teixeira Duarte, Silvia Aparecida Teixeira, Luis E. Gonzalez‐Reyes, Rui Manuel Reis · 2021 · Current Oncology
  49. G9a/EHMT2 is a Potential Prognostic Biomarker and Molecular Target in SHH Medulloblastoma
    Bárbara Kunzler Souza, Natália Hogetop Freire, Mariane da Cunha Jaeger, Caroline Brunetto de Farias, Algemir Lunardi Brunetto, Andre Tessainer Brunetto, Rafael Roesler · 2022 · NeuroMolecular Medicine
  50. Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma development
    Marina Danilenko, Masood Zaka, Claire Keeling, Stephen Crosier, Stephanie Lyman, Martina Anna Finetti, Daniel Williamson, Rafiqul Hussain, Jonathan M Coxhead, Peixun Zhou et al. · 2022 · Acta Neuropathologica
  51. Nanomedicine approaches for medulloblastoma therapy
    Chaemin Lim, Jain Koo, Kyung Taek Oh · 2022 · Journal of Pharmaceutical Investigation
  52. Metabolic rewiring in MYC-driven medulloblastoma by BET-bromodomain inhibition
    Vittoria Graziani, Aida Rodriguez‐Garcia, Lourdes Sainero‐Alcolado, Adrien D. Le Guennec, Marie Arsenian‐Henriksson, Maria R. Conte · 2023 · Scientific Reports
  53. Cell-Free DNA Extracted from CSF for the Molecular Diagnosis of Pediatric Embryonal Brain Tumors
    Mathieu Chicard, Yasmine Iddir, Julien Masliah‐Planchon, Valérie Combaret, Valéry Attignon, Alexandra Saint‐Charles, Didier Frappaz, Cécile Faure‐Conter, Kévin Beccaria, Pascale Varlet et al. · 2023 · Cancers
  54. The mitochondrial NADH shuttle system is a targetable vulnerability for Group 3 medulloblastoma in a hypoxic microenvironment
    Julie Contenti, Yongjian Guo, A. Mazzu, Marie Irondelle, Matthieu Rouleau, Chiara Lago, Gloria Leva, Luca Tiberi, Issam Ben‐Sahra, Frédéric Bost et al. · 2023 · Cell Death and Disease
  55. Pediatric Central Nervous System Embryonal Tumors: Presentation, Diagnosis, Therapeutic Strategies, and Survivorship—A Review
    Rebecca J. Ronsley, Bonnie Cole, Tyler Garrett Ketterl, Jason N. Wright, Ralph P. Ermoian, Lindsey Marie Hoffman, Ashley Margol, Sarah E. S. Leary · 2024 · Pediatric Neurology
  56. The Illumina Infinium methylation assay for genome-wide methylation analyses
    Kazuhiko Nakabayashi · 2020 · Elsevier eBooks
  57. Epigenetic regulation in medulloblastoma pathogenesis revealed by genetically engineered mouse models
    Ryo Shiraishi, Daisuke Kawauchi · 2021 · Cancer Science
  58. Pre- and Post-Treatment Imaging of Primary Central Nervous System Tumors in the Molecular and Genetic Era
    Sung Soo Ahn, Soonmee Cha · 2021 · Korean Journal of Radiology
  59. Cross-Talk Between Histone Methyltransferases and Demethylases Regulate REST Transcription During Neurogenesis
    Jyothishmathi Swaminathan, Shinji Maegawa, Shavali Shaik, Ajay Sharma, Javiera B Bravo-Alegria, Lei Ming Guo, Lin Xu, Arif O. Harmanci, Vidya Gopalakrishnan · 2022 · Frontiers in Oncology
  60. A Druggable UHRF1/DNMT1/GLI Complex Regulates Sonic Hedgehog–Dependent Tumor Growth
    Fan Yang, Jezabel Rodríguez‐Blanco, Jun Long, Marzena Swiderska‐Syn, Daniel T. Wynn, Bin Li, Chen Shen, Anmada Nayak, Yuguang J. Ban, Xiaodian Sun et al. · 2022 · Molecular Cancer Research
  61. Inhibition of enhancer of zest homologue 2 is a potential therapeutic target for high‐MYC medulloblastoma
    Manabu Natsumeda, Yang Liu, Satoshi Nakata, Hiroaki Miyahara, Allison Rose Hanaford, Sama Ahsan, Duncan S. Stearns, Nicolas Skuli, Ulf D. Kahlert, Eric H. Raabe et al. · 2019 · Neuropathology
  62. Biological characterization of the UW402, UW473, ONS-76 and DAOY pediatric medulloblastoma cell lines
    Ricardo Bonfim-Silva, Karina Bezerra Salomão, Thais Valéria Costa de Andrade Pimentel, Camila Branquinho Menezes, Patrícia Vianna Bonini Palma, Aparecida Maria Fontes · 2019 · Cytotechnology
  63. Identification of Core Genes and Pathways in Medulloblastoma by Integrated Bioinformatics Analysis
    Yuduo Guo, Peng Huang, Weihai Ning, Hongwei Zhang, Chunjiang Yu · 2020 · Journal of Molecular Neuroscience
  64. Primary leptomeningeal medulloblastoma: a case-based review
    Carmela Russo, Maria Rosaria Scala, Pietro Spennato, Anna Nastro, Maria Elena Errico, Lucia De Martino, Giuseppe Cinalli · 2022 · Child s Nervous System
  65. OTX Genes in Adult Tissues
    Alessandro Terrinoni, Giovanni Micheloni, Vittoria Moretti, Sabrina Caporali, Sergio Bernardini, Marilena Minieri, Massimo Pieri, Cristina Giaroni, Francesco Acquati, Lucy Costantino et al. · 2023 · International Journal of Molecular Sciences
  66. A simple and scalable zebrafish model of Sonic hedgehog medulloblastoma
    Mattie J. Casey, Priya P. Chan, Qing Li, Ju‐Fen Zhu, Cicely A. Jette, Missia Kohler, Benjamin R. Myers, Rodney A. Stewart · 2024 · Cell Reports
  67. EphA2 and phosphoantigen-mediated selective killing of medulloblastoma by γδT cells preserves neuronal and stem cell integrity
    Lola Boutin, Mingzhi Liu, Julie Déchanet‐Merville, Oscar C. Bedoya-Reina, Margareta Wilhelm · 2025 · OncoImmunology
  68. Single-cell deconstruction of medulloblastoma microenvironment elucidates subtype-specific immune architectures and prognostic molecular signatures
    Hong Zhou, Qu‐Jing Gai, Yan Qian, Yue-Xi Zhu, Shuai Zhang, Zi-Dong Liu, Yan Qin, Yong-Lin Zuo, Si-Di Li, Si-Di Li et al. · 2025 · Cancer Letters
  69. Epigenetics and survivorship in pediatric brain tumor patients
    Debanjan Bhattacharya, Scott L. Pomeroy, Daniel Pomeranz Krummel, Soma Sengupta · 2020 · Journal of Neuro-Oncology
  70. Two machine learning methods identify a metastasis-related prognostic model that predicts overall survival in medulloblastoma patients
    Kui Chen, Bingsong Huang, Shan Yan, Siyi Xu, Keqin Li, Kuiming Zhang, Qi Wang, Zhongwei Zhuang, Liang Wei, Yanfei Zhang et al. · 2020 · Aging
  71. Medulloblastoma in adults – reviewing the literature from a surgeon’s point of view
    Thomas Eibl, Alexander Hammer, Eduard Yakubov, Cristiane Blechschmidt, Alexander Kalisch, Hans Herbert Steiner · 2021 · Aging
  72. Defining the Spectrum, Treatment and Outcome of Patients With Genetically Confirmed Gorlin Syndrome From the HIT-MED Cohort
    Katja Kloth, Denise Obrecht, Dominik Sturm, Torsten Pietsch, Monika Warmuth‐Metz, Brigitte Bison, Martin Mynarek, Stefan Rutkowski · 2021 · Frontiers in Oncology
  73. Enhanced Survival of High-Risk Medulloblastoma-Bearing Mice after Multimodal Treatment with Radiotherapy, Decitabine, and Abacavir
    Marieke Gringmuth, Jenny Walther, Sebastian Greiser, Magali Toussaint, Benjamin Schwalm, Marcel Kool, Rolf‐Dieter Kortmann, Annegret Glasow, Ina Patties · 2022 · International Journal of Molecular Sciences
  74. Rare central nervous system tumors in adults: a population-based study of ependymomas, pilocytic astrocytomas, medulloblastomas, and intracranial germ cell tumors
    Vincent K.Y. Ho, Anja Gijtenbeek, Michiel Wagemakers, Walter Taal, Myra Ellen Van Linde, Annemarie T. Swaak‐Kragten, Erkan Kurt, Hiska L. van der Weide, Pieter Wesseling, Filip De Vos et al. · 2022 · Neuro-Oncology Advances
  75. Paediatric brain tumours in Singapore: A 15-year epidemiological and outcome study
    Sherry J. Liu, Min Yi Natalie Aw, Mervyn Jun Rui Lim, Wan Tew Seow, David C.Y. Low, Miriam Santiago Kimpo, Enrica E. K. Tan, Tseng Tsai Yeo, Sharon Y. Y. Low, Vincent Diong Weng Nga · 2022 · Journal of Clinical Neuroscience
  76. Individualized discovery of rare cancer drivers in global network context
    Iurii Petrov, Andrey Alexeyenko · 2022 · eLife
  77. How do we approach the management of medulloblastoma in young children?
    Lucie Lafay‐Cousin, Lorena Baroni, Vijay Ramaswamy, Éric Bouffet · 2022 · Pediatric Blood & Cancer
  78. Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes
    Andrey Korshunov, Konstantin Okonechnikov, Daniel Schrimpf, Svenja Tonn, Martin Mynarek, Jan Köster, Philipp Sievers, Till Milde, Felix Sahm, David Jones et al. · 2023 · Acta Neuropathologica
  79. Review of the impact of molecular analysis on the therapy of medulloblastoma
    Supriya Sarvode, Amar J. Gajjar · 2023 · Pediatric Hematology Oncology Journal
  80. The LIN28B –let‐7– PBK pathway is essential for group 3 medulloblastoma tumor growth and survival
    Shubin Shahab, Christianna M. Roggeveen, Jiarong Sun, Haritha Kunhiraman, Leon McSwain, Kyle Juraschka, Sachin A. Kumar, Olivier Saulnier, Michael D. Taylor, Matthew Schniederjan et al. · 2023 · Molecular Oncology
  81. Angiogenesis and Lymphangiogenesis in Medulloblastoma Development
    Manon Penco-Campillo, Gilles Pagès, Sonia Martial · 2023 · Biology
  82. MYC Promotes Aggressive Growth and Metastasis of a WNT-Medulloblastoma Mouse Model
    Rachel Hartley, Timothy N. Phoenix · 2023 · Developmental Neuroscience
  83. DUBing Primary Tumors of the Central Nervous System: Regulatory Roles of Deubiquitinases
    Thomas C. Klonisch, Susan E. Logue, Sabine Hombach‐Klonisch, Jerry P. Vriend · 2023 · Biomolecules
  84. Chronic AMPK inactivation slows SHH medulloblastoma progression by inhibiting mTORC1 signaling and depleting tumor stem cells
    Daniel Shiloh Malawsky, Taylor Dismuke, Hedi Liu, Ethan Castellino, Jay E. Brenman, Biplab Dasgupta, Andrey P. Tikunov, Timothy R. Gershon · 2023 · iScience
  85. Targeting Super-Enhancer–Driven Transcriptional Dependencies Suppresses Aberrant Hedgehog Pathway Activation and Overcomes Smoothened Inhibitor Resistance
    Yi Sui, Teng Wang, Yanqing Mei, Ying Zhu, Wenyan Jiang, Jiayi Shen, Siyuan Yan, Wenjie Lu, Kewen Zhao, Jialin Mo et al. · 2024 · Cancer Research
  86. Targeting protein synthesis pathways in MYC-amplified medulloblastoma
    Devendra Kumar, Ranjana Kumari Kanchan, Nagendra K. Chaturvedi · 2025 · Discover Oncology
  87. Medulloblastomas in adolescents and adults – Can the pediatric experience be extrapolated?
    Didier Frappaz, Cécile Faure‐Conter, Alice Bonneville-Levard, Marc Barritault, David Meyronet, Marie‐Pierre Sunyach · 2018 · Neurochirurgie
  88. A functional genomics approach to identify pathways of drug resistance in medulloblastoma
    Kelsey C. Bertrand, Cláudia C. Faria, Patryk Skowron, Amanda J. Luck, Livia Garzia, Xiaochong Wu, Sameer Agnihotri, Christian A. Smith, Michael D. Taylor, Stephen C. Mack et al. · 2018 · Acta Neuropathologica Communications
  89. Effective Inhibition of MYC-Amplified Group 3 Medulloblastoma Through Targeting EIF4A1
    Yang Zhao, Tiantian Li, Shuaiwei Tian, Wei Meng, Yi Sui, Jian Yang, Baocheng Wang, Zhuangzhuang Liang, Heng Zhao, Yipeng Han et al. · 2020 · Cancer Management and Research
  90. Ten-eleven translocation protein 1 modulates medulloblastoma progression
    Hyerim Kim, Yunhee Kang, Yujing Li, Li Chen, Li Lin, Nicholas D. Johnson, Dan Zhu, M. Hope Robinson, Leon McSwain, Benjamin G. Barwick et al. · 2021 · Genome biology
  91. Predictive modeling of resistance to SMO inhibition in a patient-derived orthotopic xenograft model of SHH medulloblastoma
    Sonja Krausert, Sebastian Brabetz, Norman L. Mack, Felix Schmitt-Hoffner, Benjamin Schwalm, Heike Peterziel, Aileen Mangang, Tim Holland‐Letz, Laura Sieber, Andrey Korshunov et al. · 2022 · Neuro-Oncology Advances
  92. Pediatric Pan-Central Nervous System Tumor Methylome Analyses Reveal Immune-Related LncRNAs
    Yongsheng Li, Sicong Xu, Dahua Xu, Tao Pan, Jing Guo, Shuo Gu, Qiuyu Lin, Xia Li, Kongning Li, Wei Xiang · 2022 · Frontiers in Immunology
  93. The developmental stage of the medulloblastoma cell-of-origin restricts Sonic hedgehog pathway usage and drug sensitivity
    Marlinde J. Smit, Tosca E. I. Martini, Inna Armandari, Irena Bočkaj, Walderik W. Zomerman, Eduardo Sabino de Camargo Magalhães, Zillah Siragna, Tiny Meeuwsen-de Boer, Frank J.G. Scherpen, Mirthe H. Schoots et al. · 2022 · Journal of Cell Science
  94. Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma
    Meng Li, Yujie Han, Chaochen Wang, Wenfeng Kang, Wenyan Jiang, Lei Zhang, Yujie Tang · 2022 · Journal of Experimental & Clinical Cancer Research
  95. Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors
    Margot Lazow, Christine E. Fuller, Andrew T. Trout, Joseph R. Stanek, Jaime Reuss, Brian K. Turpin, Sara Szabo, Ralph Salloum · 2022 · Frontiers in Oncology
  96. Tumor-acquired somatic mutation affects conformation to abolish ABCG2-mediated drug resistance
    Tomoka Gose, Ali Rasouli, Sepehr Dehghani‐Ghahnaviyeh, Po‐Chao Wen, Yao Wang, John Lynch, Yu Fukuda, Talha Shafi, Robert C. Ford, Emad Tajkhorshid et al. · 2024 · Drug Resistance Updates
  97. Role of mammalian long non-coding RNAs in normal and neuro oncological disorders
    Neetu Singh · 2021 · Genomics
  98. DNA polymerase β deficiency in the p53 null cerebellum leads to medulloblastoma formation
    Jusik Kim, Jaemi Kim, Youngsoo Lee · 2018 · Biochemical and Biophysical Research Communications
  99. Signaling pathway deregulation and molecular alterations across pediatric medulloblastomas
    Benoît Lhermitte, Anne-Florence Blandin, Andres Hugo Coca, Éric Guérin, A. Durand, Natacha Entz‐Werlé · 2021 · Neurochirurgie
  100. ComPath: An ecosystem for exploring, analyzing, and curating mappings across pathway databases
    Daniel Domingo‐Fernándéz, Charles Tapley Hoyt, Carlos Bobis-Álvarez, Josep Marín-Llaó, Martin Hofmann‐Apitius · 2018 · bioRxiv (Cold Spring Harbor Laboratory)